| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8449246 | European Journal of Cancer Supplements | 2008 | 6 Pages |
Abstract
Data reported in this study support the observation that basal bilirubin levels are a biomarker able to predict, at least in part, the clinical efficacy and toxicity of CPT-11-based chemotherapy in patients with advanced colorectal carcinoma.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Giuseppe Colucci, Francesco Giuliani, Evaristo Maiello, A. Logroscino, Vittorio Gebbia,